source
- FDA’s top gene-therapy regulator Vijay Kumar steps down amid leadership shake-upVijay Kumar, the acting director of the FDA office that reviews cell and gene therapies, has announced he will leave his position. In an email to staff, Kumar said he reflected on his tenure and de…
- STAT+: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney generalAstraZeneca agreed to pay $34 million to settle claims that the company paid kickbacks to improperly influence prescriptions paid for by Texas Medicaid.STAT · 1mo ago↗ source